Metropolitan Life Insurance Company (MetLife)’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-18,235
Closed -$1.37M 2715
2015
Q3
$1.37M Buy
18,235
+187
+1% +$14K 0.01% 1046
2015
Q2
$1.36M Buy
18,048
+2,759
+18% +$148K 0.01% 1117
2015
Q1
$767K Buy
15,289
+1,614
+12% +$67.7K 0.01% 1353
2014
Q4
$474K Hold
13,675
﹤0.01% 1795
2014
Q3
$448K Hold
13,675
﹤0.01% 1785
2014
Q2
$525K Buy
13,675
+3,082
+29% +$108K ﹤0.01% 1798
2014
Q1
$421K Sell
10,593
-213
-2% -$9.53K ﹤0.01% 1933
2013
Q4
$403K Buy
10,806
+2,127
+25% +$88.2K ﹤0.01% 1961
2013
Q3
$397K Hold
8,679
﹤0.01% 1918
2013
Q2
$235K Buy
+8,679
New +$199K ﹤0.01% 2238

Metropolitan Life Insurance Company (MetLife)'s KYTH Position: Q4 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 18,235 shares — an estimated $1.37M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $1.37M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 18,235 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $1.37M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.37M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2015, filed 11 Feb 2016.